Professor Mike Clarke
- Director of the Northern Ireland Clinical Trials Unit
- Northern Ireland Methodology Hub Lead, Queen’s University, Belfast
Professor Mike Clarke has nearly 30 years’ experience in the design and conduct of rigorous assessments of the effects of interventions through the use of randomised trials and systematic reviews. He joined CTSU in 1989 following a BA in chemistry and while finishing his DPhil on the history and epidemiology of suicide at the University of Oxford. Since then, he has been part of the Secretariat for the breast cancer overview, with a particular focus on the effects of ovarian ablation or suppression for women with early breast cancer. He was Director of the UK Cochrane Centre from 2002 to 2011 and now leads the Northern Ireland Methodology Hub at Queen’s University, Belfast and is Director of the Northern Ireland Clinical Trials Unit.
Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial.
Lois N. et al, (2019), Trials, 20
Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement.
Kirkham JJ. et al, (2019), Trials, 20
The James Lind Initiative: books, websites and databases to promote critical thinking about treatment claims, 2003 to 2018.
Chalmers I. et al, (2019), Res Involv Engagem, 5
Role of supplementary material in biomedical journal articles: surveys of authors, reviewers and readers.
Price A. et al, (2018), BMJ Open, 8
Doing trials within trials: a qualitative study of stakeholder views on barriers and facilitators to the routine adoption of methodology research in clinical trials.
Rick J. et al, (2018), Trials, 19